JP2024546641A5 - - Google Patents

Info

Publication number
JP2024546641A5
JP2024546641A5 JP2024533092A JP2024533092A JP2024546641A5 JP 2024546641 A5 JP2024546641 A5 JP 2024546641A5 JP 2024533092 A JP2024533092 A JP 2024533092A JP 2024533092 A JP2024533092 A JP 2024533092A JP 2024546641 A5 JP2024546641 A5 JP 2024546641A5
Authority
JP
Japan
Prior art keywords
composition according
nucleic acid
acid molecules
composition
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546641A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/052207 external-priority patent/WO2023107593A2/en
Publication of JP2024546641A publication Critical patent/JP2024546641A/ja
Publication of JP2024546641A5 publication Critical patent/JP2024546641A5/ja
Pending legal-status Critical Current

Links

JP2024533092A 2021-12-09 2022-12-08 免疫細胞へのインビボ送達 Pending JP2024546641A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163287725P 2021-12-09 2021-12-09
US63/287,725 2021-12-09
PCT/US2022/052207 WO2023107593A2 (en) 2021-12-09 2022-12-08 In vivo delivery to immune cells

Publications (2)

Publication Number Publication Date
JP2024546641A JP2024546641A (ja) 2024-12-26
JP2024546641A5 true JP2024546641A5 (https=) 2026-01-07

Family

ID=86731192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533092A Pending JP2024546641A (ja) 2021-12-09 2022-12-08 免疫細胞へのインビボ送達

Country Status (4)

Country Link
EP (1) EP4444361A4 (https=)
JP (1) JP2024546641A (https=)
AU (1) AU2022407035A1 (https=)
WO (1) WO2023107593A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL313473A (en) 2021-12-15 2024-08-01 Interius Biotherapeutics Inc Pseudotyped viral particles, compositions comprising the same, and uses thereof
KR20250057777A (ko) 2022-07-25 2025-04-29 인테리우스 바이오테라퓨틱스, 인코포레이티드 돌연변이된 폴리펩티드, 이를 포함하는 조성물, 및 그 용도(mutated polypeptides, compositions comprising the same, and uses thereof)
CN117343908B (zh) * 2023-12-05 2024-02-09 南京大学 一种通过真菌精准激活的car-t细胞、制备方法、应用及药物组合物
WO2025235801A1 (en) 2024-05-08 2025-11-13 City Of Hope Antibodies targeted to osteopontin and uses thereof for reducing resistance of solid tumors immune cell therapy
CN120695211A (zh) * 2025-06-25 2025-09-26 广东医科大学附属医院 mRNA组合物及其在制备肝纤维化治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311901B2 (en) * 2003-10-10 2007-12-25 Samyang Corporation Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
US10188749B2 (en) * 2016-04-14 2019-01-29 Fred Hutchinson Cancer Research Center Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
EP3561053A1 (en) * 2018-04-26 2019-10-30 Baylor College of Medicine Immune effector cells and molecular adaptors with an antigen cytokine complex for effective cancer immunotherapy
CN114127297A (zh) * 2019-03-26 2022-03-01 加维什-加利里生物应用有限公司 遗传重编程的表达car的treg
IL295810B2 (en) * 2020-03-11 2026-01-01 Univ Pennsylvania Methods and compositions for gene delivery using a modified viral particle
JP7851254B2 (ja) * 2020-03-20 2026-04-24 オルナ セラピューティクス インコーポレイテッド 環状ｒｎａ組成物及び方法
CA3187138A1 (en) * 2020-06-26 2021-12-30 Carisma Therapeutics Inc. Mrna transfection of immune cells

Similar Documents

Publication Publication Date Title
JP2024546641A5 (https=)
JP7308000B2 (ja) Ｖｅｇｆ－ａポリペプチドをコードする改変ｒｎａを送達するための脂質ナノ粒子
US10973909B1 (en) Coronavirus vaccine
JP6990176B2 (ja) メッセンジャーリボ核酸薬物の治療投与のための方法
JP2023059880A (ja) 連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチド及びその使用
JP2023522249A5 (https=)
KR20190020299A (ko) 면역 조정 폴리펩타이드를 암호화하는 mRNA의 조합물 및 이의 용도
JP2023523580A (ja) コロナウイルスワクチン
Abu Abed Gene therapy avenues and COVID-19 vaccines
AU2016286364B2 (en) ATP-binding cassette family coding polyribonucleotides and formulations thereof
KR20240035836A (ko) 지질 나노-에멀젼 입자에 흡착된 rna 및 그 제제
US20230149535A1 (en) Vaccines for coronavirus and methods of using the same
Huang et al. Advances in development of mRNA-based therapeutics
WO2021042944A1 (zh) 肌肉靶向的微环dna基因治疗
CN118434436A (zh) 免疫刺激性mrna组合物及其用途
EP4342993A1 (en) Hpv infectious disease vaccine
JP2024545253A (ja) 効率的なワクチン
US11517611B2 (en) Methods of treating viral infection with a composition comprising IL-18 and IL-22
Haaijer Immunogenic versus tolerogenic mRNA Vaccines
WO2025253381A1 (en) Cyclic gmp-amp synthase variants and use thereof
EP4722367A1 (en) Mrna structure platform for protein expression with high efficiency
EP4434528A1 (en) Therapeutic nucleic acid molecule, mixture, and drug, and use thereof in treating solid tumor
EP4683666A1 (en) Peg targeting compounds for delivery of therapeutics
HK40114150A (zh) 免疫刺激性mrna组合物及其用途
WO2024197310A1 (en) Peg targeting compounds for delivery of therapeutics